TheEdgeResearch
Home / Stocks / OSSUY

Embla Medical hf. (OSSUY)

OTC Healthcare Medical - Devices
$4.15 ▲ +0.00%
Market Cap
$1.77B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.46
52-Wk Range
3.67-5.61
CEO
Sveinn Solvason
Country
IS
Currency
USD

Embla Medical hf. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Reykjavik, SU, IS. The stock last traded at $4.15, up 0.00% on the session, giving a market capitalisation of $1.77B. On trailing twelve-month figures it carries a trailing P/E of 18.93, a net margin of 9.5%. Its beta of 0.46 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
18.93
Price / Sales
1.80
Price / Book
1.94
EV / EBITDA
10.83
Gross margin
60.3%
Operating margin
13.7%
Net margin
9.5%
Return on equity
Debt / equity
0.58
Current ratio
1.25
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
4,192
IPO date
2018-05-23
Headquarters
Reykjavik, SU, IS
About Embla Medical hf.

Embla Medical hf is an international enterprise focused on orthopedics, dedicated to the innovation, enhancement, production, and worldwide distribution of non-surgical orthopedic solutions. Its business activities are organized across various geographical divisions, including the Americas, the Europe, Middle East, and Africa (EMEA) region, and a unified segment encompassing both the Americas and Asia-Pacific. The company was established in 1971 by Össur Kristinsson and has its primary corporate office situated in Reykjavík, Iceland.

Comparable companies

Embla Medical hf. is most often compared with the following Healthcare names:

ALFRYDMPHFGGNDFGNNDYHBMHFMEDGFSHPHFSTSEYTCGGYVTRLY
More research on OSSUY
OSSUY technical analysis OSSUY TheEdge Score Compare against peers
Open full interactive analysis & DCF →